Board of directors



Anders Lundberg

Chairman of the Board (member of the board since 2017)

About: Founder and CEO of a telecom equipment supplier recognized by the market and later brought to a successful IPO in 2011 on the MID-CAP list OMX-Nasdaq [TRMO:Transmode]

Other assignments: Member of the board of AJ Lundberg Kapitalförvaltning AB and Modern Car Group International AB. Deputy member of the board of Sollentunahem AB, Sollentunafastigheter 1 AB, Sollentunafastigheter 2 AB and Sollentunafastigheter 3 AB.

Holdings in the Company: 4,437 shares (corresponding to 2.4 percent of capital and votes) and 0 warrants

Dr. Michael Häggman

Board Member since 2018

About: M.D, Ph.D. associate professor, department of Urology, Akademiska University Hospital, Uppsala, Sweden. More than 30 years of experience practicing as urologist with an extensive national and international network among urologists.

Other assignments: General partner in Skrotum Kommanditbolag and deputy member of the board of Kardinaltalet AB.

Holdings in the Company: 181 shares (corresponding to 0.1 percent of capital and votes) and 1,500 warrants

Karlheinz Schmelig

Chairman of the Board (member of the board since 2017)

About: Founder and CEO of a telecom equipment supplier recognized by the market and later brought to a successful IPO in 2011 on the MID-CAP list OMX-Nasdaq [TRMO:Transmode]

Other assignments: Member of the board of AJ Lundberg Kapitalförvaltning AB and Modern Car Group International AB. Deputy member of the board of Sollentunahem AB, Sollentunafastigheter 1 AB, Sollentunafastigheter 2 AB and Sollentunafastigheter 3 AB.

Holdings in the Company: 4,437 shares (corresponding to 2.4 percent of capital and votes) and 0 warrants

Håkan Englund

Board Member since 2019

About: CEO and owner, JDS Invest. More than 30 years of operational and investment experience from life science and health care industry with focus on commercialization and business development. Håkan has held several leading management positions at Pharmacia Biotech and Phadia and has during his career developed extensive national and international relevant networks.

Other assignments: Chairman of the Board, SecureAppBox, member of the board, Immuneed, member of the board Antrad Medical, deputy board director Ultimovax (Norway), member of the board GlycoBond. Board member Stockholm/Uppsala Chamber of Commerce.

Holdings in the Company: 9,084 shares (corresponding to 4.88 percent of capital and votes) and 0 warrants

Dr. Christoph Petry

Board Member since 2019

About: Doctoral Thesis, Max-Planck Institute for Medical Research, Heidelberg, Germany. M.Sc in Chemistry, University of Erlangen, Germany. Previously founder, Managing Director and CEO of Sividon Diagnostics and Head of Siemens Healthcare Diagnostics, Molecular Research Germany as well as 10 years of experience from various management positions at Bayer.

Other assignments: Managing Director m2p-labs GmbH I Microbioreactors, Germany

Holdings in the Company: 0 shares (corresponding to 0 percent of capital and votes) and 0 warrants